At the time of writing, Exelixis Inc [EXEL] stock is trading at $34.13, down -2.04%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EXEL shares have lost -6.21% over the last week, with a monthly amount drifted -12.83%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on February 24, 2025, when Wells Fargo downgraded its rating to a Equal Weight but kept the price target unchanged to $36 for it. Previously, Morgan Stanley upgraded its rating to Overweight on January 27, 2025, and elevated its price target to $40. On January 24, 2025, downgrade downgraded it’s rating to Perform. BMO Capital Markets downgraded its rating to a Market Perform and increased its price target to $40 on December 20, 2024. BofA Securities downgraded its rating to a Neutral and raised its price target to $39 on December 17, 2024. RBC Capital Mkts reiterated a Outperform rating for this stock on October 16, 2024, and upped its price target to $34. In a note dated September 19, 2024, UBS initiated an Neutral rating and provided a target price of $30 on this stock.
For the past year, the stock price of Exelixis Inc fluctuated between $20.14 and $40.02. Currently, Wall Street analysts expect the stock to reach $34.12 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $34.13 at the most recent close of the market. An investor can expect a potential drop of -0.03% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
According to Exelixis Inc [NASDAQ:EXEL], the company’s sales were 2.17B for trailing twelve months, which represents an 18.16% jump. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.28%, Pretax Profit Margin comes in at 0.31%, and Net Profit Margin reading is 0.24%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.24 and Total Capital is 0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 33.24 points at the first support level, and at 32.35 for the second support level. However, for the 1st resistance point, the stock is sitting at 35.44, and for the 2nd resistance point, it is at 36.75.
Ratios To Look Out For
It is important to note that Exelixis Inc [NASDAQ:EXEL] has a current ratio of 3.63. In addition, the Quick Ratio stands at 3.58 and the Cash Ratio stands at 0.54. Considering the valuation of this stock, the price to sales ratio is 4.40, the price to book ratio is 4.28 and price to earnings (TTM) ratio is 19.26.
Transactions by insiders
Recent insider trading involved Haley Patrick J., EVP, Commercial, that happened on Mar 03 ’25 when 10000.0 shares were sold. Officer, PATRICK JOSEPH HALEY completed a deal on Mar 03 ’25 to buy 10000.0 shares. Meanwhile, Director Smith Julie sold 54514.0 shares on Feb 27 ’25.
